| 1 | Hum. Mol. Genet. 2013 Dec 22: 5001-14 |
|---|---|
| PMID | 23904455 |
| Title | Transcriptome study of differential expression in schizophrenia. |
| Abstract | schizophreniagenome-wide association studies (GWAS) have identified common SNPs, rare copy number variants (CNVs) and a large polygenic contribution to illness risk, but biological mechanisms remain unclear. Bioinformatic analyses of significantly associated genetic variants point to a large role for regulatory variants. To identify gene expression abnormalities inschizophrenia, we generated whole-genome gene expression profiles using microarrays on lymphoblastoid cell lines (LCLs) from 413 cases and 446 controls. Regression analysis identified 95 transcripts differentially expressed by affection status at a genome-wide false discovery rate (FDR) of 0.05, while simultaneously controlling for confounding effects. These transcripts represented 89 genes with functions such as neurotransmission, gene regulation, cell cycle progression, differentiation, apoptosis, microRNA (miRNA) processing and immunity. This functional diversity is consistent withschizophrenia's likely significant pathophysiological heterogeneity. The overall enrichment of immune-related genes among those differentially expressed by affection status is consistent with hypothesized immune contributions toschizophreniarisk. The observed differential expression of extended major histocompatibility complex (xMHC) region histones (HIST1H2BD, HIST1H2BC, HIST1H2BH, HIST1H2BG and HIST1H4K) converges with the genetic evidence from GWAS, which find the xMHC to be the most significant susceptibility locus. Among the differentially expressed immune-related genes, B3GNT2 is implicated in autoimmune disorders previously tied toschizophreniarisk (rheumatoid arthritis and Graves' disease), andDICER1is pivotal in miRNA processing potentially linking to miRNA alterations inschizophrenia(e.g. MIR137, the second strongest GWAS finding). Our analysis provides novel candidate genes for further study to assess their potential contribution toschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 2 | Sci Rep 2015 -1 5: 18209 |
| PMID | 26666178 |
| Title | Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development. |
| Abstract | schizophreniais a heritable, heterogeneous common psychiatric disorder. In this study, we evaluated the hypothesis that de novo variants (DNVs) contribute to the pathogenesis ofschizophrenia. We performed exome sequencing in Chinese patients (N?=?45) withschizophreniaand their unaffected parents (N?=?90). Forty genes were found to contain DNVs. These genes had enriched transcriptional co-expression profile in prenatal frontal cortex (Bonferroni corrected p?DICER1and ABCA2) harboring the damaging de novo mutations are strongly prioritized as susceptibility genes by multiple evidences. Our findings in Chineseschizophrenicpatients indicate the pathogenic role of DNVs, supporting the hypothesis thatschizophreniais a neurodevelopmental disease. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 3 | Sci Rep 2015 -1 5: 18209 |
| PMID | 26666178 |
| Title | Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development. |
| Abstract | schizophreniais a heritable, heterogeneous common psychiatric disorder. In this study, we evaluated the hypothesis that de novo variants (DNVs) contribute to the pathogenesis ofschizophrenia. We performed exome sequencing in Chinese patients (N?=?45) withschizophreniaand their unaffected parents (N?=?90). Forty genes were found to contain DNVs. These genes had enriched transcriptional co-expression profile in prenatal frontal cortex (Bonferroni corrected p?DICER1and ABCA2) harboring the damaging de novo mutations are strongly prioritized as susceptibility genes by multiple evidences. Our findings in Chineseschizophrenicpatients indicate the pathogenic role of DNVs, supporting the hypothesis thatschizophreniais a neurodevelopmental disease. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 4 | Mol. Neurobiol. 2015 Oct -1: -1 |
| PMID | 26491028 |
| Title | 抑郁、细胞因子和细胞因子的Treatment Interactions Modulate Gene Expression in Antipsychotic Na�ve First Episode Psychosis. |
| Abstract | Inschizophrenia, genetic and environmental factors affect neurodevelopment and neuroprogressive trajectory. Altered expression of neuro-immune genes and increased levels of cytokines are observed, especially in patients with comorbid depression. However, it remains unclear whether circulating levels of cytokines and expression of these genes are associated, and how antipsychotic treatments impact this association. Relationships between messenger RNA (mRNA) expression of 11schizophrenia-related genes and circulating levels of cytokines (interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-?) were analyzed in 174 antipsychotic na�ve first episode psychosis (FEP) and in 77 healthy controls. A subgroup of 72 patients was reassessed after treatment with risperidone. FEP patients were divided into those with and without depression. FEP patients with depression showed increased COMT expression and decreased NDEL1 expression. Increased IL-6 was associated with lowered AKT1 and DROSHA expression, while increased IL-10 was associated with increased NDEL1, DISC1, and MBP expression. IL-6 levels significantly increased the risperidone-induced expression of AKT1,DICER1，Drosha和Comt mRNA。FEP中的差异mRNA基因表达在很大程度上与细胞因子水平升高有关。虽然增加的IL-6可能会下调Akt介导的细胞功能和参与microRNA（miRNA）机械的基因失调，但增加的IL-10具有神经保护性能。IL-6水平的升高可能启用基因的表达（Akt1，DICER1, DROSHA, and COMT) in response to risperidone, suggesting that cytokine?�?treatment?�?gene interactions may improve cell function profiles. FEP patients with depression show a different gene expression profile reinforcing the theory that depression in FEP is a different phenotype. |
| SCZ Keywords | schizophrenia, schizophrenic |